Hematology
Conference Coverage
Pembrolizumab prolonged PFS vs. brentuximab vedotin in r/r Hodgkin lymphoma
Pembrolizumab should be considered “the preferred treatment option and the standard of care” for patients with classic Hodgkin lymphoma not...
Latest News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available...
News
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
Reports From the Field
Implementation of a Patient Blood Management Program in a Large, Diverse Multi-Hospital System
News
Inflammation, thrombosis biomarkers tied to COVID-19 deaths
“Of particular interest is the finding that over three quarters of critically ill patients required a ventilator and almost one third required...
Conference Coverage
Universal CAR-T therapy produces CRs in relapsed/refractory T-ALL
All five patients studied achieved a complete response, though one patient had a morphological relapse.
Conference Coverage
Blood test detects colon cancer in single-center study
Results from a study of 354 patients show a blood test spotting signs of colon cancer and abnormal growths.
News
COVID-19–associated coagulopathy
Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.
News
COVID-19 pulmonary severity ascribed to coagulation differences
Conference Coverage
Metastatic cancer linked to worse outcomes of COVID-19